LA SB394 | 2022 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on June 18 2022 - 100% progression
Action: 2022-06-18 - Effective date 1/1/2023.
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on June 18 2022 - 100% progression
Action: 2022-06-18 - Effective date 1/1/2023.
Text: Latest bill text (Chaptered) [PDF]
Summary
Requires coverage for drugs under certain conditions and the drug is approved by the United States Food and Drug Administration. (1/1/23) (EN INCREASE SG EX See Note)
Title
Requires coverage for drugs under certain conditions and the drug is approved by the United States Food and Drug Administration. (1/1/23) (EN INCREASE SG EX See Note)
Sponsors
Roll Calls
2022-06-05 - Senate - Senate Vote on SB 394 CONCUR (#1358) (Y: 33 N: 1 NV: 0 Abs: 4) [PASS]
2022-06-03 - House - House Vote on SB 394 FINAL PASSAGE (#1447) (Y: 92 N: 0 NV: 0 Abs: 13) [PASS]
2022-04-18 - Senate - Senate Vote on SB 394 FINAL PASSAGE (#303) (Y: 36 N: 0 NV: 0 Abs: 2) [PASS]
2022-06-03 - House - House Vote on SB 394 FINAL PASSAGE (#1447) (Y: 92 N: 0 NV: 0 Abs: 13) [PASS]
2022-04-18 - Senate - Senate Vote on SB 394 FINAL PASSAGE (#303) (Y: 36 N: 0 NV: 0 Abs: 2) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2022-06-18 | Senate | Effective date 1/1/2023. |
| 2022-06-18 | Senate | Signed by the Governor. Becomes Act No. 703. |
| 2022-06-06 | Senate | Sent to the Governor by the Secretary of the Senate on 6/8/2022. |
| 2022-06-06 | House | Signed by the Speaker of the House. |
| 2022-06-06 | Senate | Enrolled. Signed by the President of the Senate. |
| 2022-06-05 | Senate | Rules suspended. Amendments proposed by the House read and concurred in by a vote of 33 yeas and 1 nays. |
| 2022-06-03 | Senate | Received from the House with amendments. |
| 2022-06-03 | House | Read third time by title, roll called on final passage, yeas 92, nays 0. Finally passed, ordered to the Senate. |
| 2022-06-02 | House | Scheduled for floor debate on 06/03/2022. |
| 2022-05-25 | House | Read by title, passed to 3rd reading. |
| 2022-05-24 | House | Reported without Legislative Bureau amendments. |
| 2022-05-23 | House | Reported favorably (13-0). Referred to the Legislative Bureau. |
| 2022-05-05 | House | Read by title, amended, recommitted to the Committee on Appropriations. |
| 2022-05-04 | House | Reported with amendments (10-0). To be recommitted to the Committee on Appropriations. |
| 2022-04-20 | House | Read by title, under the rules, referred to the Committee on Insurance. |
| 2022-04-19 | House | Received in the House from the Senate, read by title, lies over under the rules. |
| 2022-04-18 | Senate | Senate floor amendments read and adopted. Read by title and passed by a vote of 36 yeas and 0 nays; ordered reengrossed and sent to the House. Motion to reconsider tabled. |
| 2022-04-14 | Senate | Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage. |
| 2022-04-13 | Senate | Reported with amendments. |
| 2022-03-22 | Senate | Read second time by title and referred to the Committee on Insurance. |
| 2022-03-21 | Senate | Rules suspended. Introduced in the Senate. Read by title and placed on the Calendar for a second reading. |
